<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Background/Aims:To investigate the therapeutic result of RFA and the factors predicting recurrence after RFA in patients with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Methodology: We reviewed 33 patients who had <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastases</z:e> and underwent curative RFA </plain></SENT>
<SENT sid="2" pm="."><plain>Statistical analysis of the determinants of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> recurrence was done by sex, age, site and differentiation of the primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, lesion size, location within the liver, ablative margin and presence of vessels contiguous to the mass and time from the initial <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> to RFA </plain></SENT>
<SENT sid="3" pm="."><plain>Results: Marginal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> recurrence was seen at the ablation margin in 13 (25%) of 52 lesions </plain></SENT>
<SENT sid="4" pm="."><plain>Lesions with an ablative margin of 5mm or more had longer marginal recurrence-free interval compared to lesions with an ablative margin of less than 5mm </plain></SENT>
<SENT sid="5" pm="."><plain>The patients with primary <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> had a significantly longer distant recurrence-free interval compared to patients with non-colorectal <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Conclusions: Percutaneous RFA is an effective alternative modality for the treatment of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastases</z:e> from various primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and has a relatively low recurrence rate </plain></SENT>
<SENT sid="7" pm="."><plain>The presence of an ablative margin was a significant prognostic factor for marginal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> recurrence </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, a new hepatic lesion or extrahepatic was significantly influenced by the site of the primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>